Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Any thing new for EVOK? How long do you think we have to wait for the next company update regarding the FDA approval of the drug or their next financial repot to be released. Do you have any idea? Price is keeping steady and moving up slow and steady, that is good in my opinion.
After market closed price has gone up to 2.93 wander if any news could be expected next week.
We are hearing this in the past one year still no dilution and no reverse spit.
I agree 100% on your message. Have good weekend.
It will go up when people come to understand the value of this company. Too soon to come to any conclusion until they assimilate the whole financials and the direction the company moving up. It will move slow and steady no hype here.
Thank you for your reply, much appreciated.
Did anybody participate in the conference call? Any thing said could enhance he stock value in short time or any indication that someone with the deep pocket is in interested in buy this company? Your views regarding this will be much appreciated.
EVOK : Notable earnings after Wednesday’s close
5:35 pm, Tue, Mar. 14, 2017
Read now »
We make hit $4 before end of tomorrow anticipation of the financial reports to be released after market closed tomorrow. I beleive 4 Pharma companies are inerested in going for a JV with Evoke Pharma if that comes through this is will surpass the 52 weeks high for sure. This is becoming interesting now.
No panic people get excited and sell are making a big, big mistake. To me there is nothing wrong here. More people are interested in buy this at a low price and hold to get there return to grow in multiples in time to come. Please read this passage carfully to understand the potential of this company to do extremely well in a short time frame but you have to be patient.
Read this: A number of large investors have recently added to or reduced their stakes in the stock. State Treasurer State of Michigan increased its stake in Evoke Pharma by 460.0% in the third quarter. State Treasurer State of Michigan now owns 140,000 shares of the specialty pharmaceutical company’s stock worth $316,000 after buying an additional 115,000 shares during the last quarter. Vanguard Group Inc. increased its stake in Evoke Pharma by 5.0% in the second quarter. Vanguard Group Inc. now owns 62,381 shares of the specialty pharmaceutical company’s stock worth $427,000 after buying an additional 2,947 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its stake in Evoke Pharma by 2.0% in the second quarter. Bank of New York Mellon Corp now owns 23,679 shares of the specialty pharmaceutical company’s stock worth $162,000 after buying an additional 464 shares during the last quarter. 5.13% of the stock is currently owned by institutional investors.
What does it indicate all the big investors are buy and holding becouse they know what this is going be when FDA approve the drug for marking.
Those who sell now will get caught unaware when this moves up suddenly. This is not the time for day trading on this shares. People who sell now are going to lose a lot when more updates are put out by the company.
What do you think this could trade after FDA approval is given? We have to bear in mind shares were trading around $11 before the Phase three trial floped.
I think this is holding well before the next run could be early as next week.
We may get some updates by early next week. Then this will run mad and break the 54 weeks highs
Can't you see what was happening in the past week. Insiders are buying for what? they know where this is going to be before the end of March, so they are loading up. Generally when insiders buy and accumulate it's always a good sign. I go buy this principle and buy and hold until this move higher. It has an history of trading above $11.00 When the FDA approval is given it's going go beyond the previous highs.
More insiders buy a very good sign. Current level wont stay too long at this price in my honest opinion.
This is from the last new release by the company everyone here should read to understand the potential of the company "A new 2016 Arcview Market Research study shows North American Marijuana sales to top $20.2 Billion by 2021. The executive summary of this groundbreaking report was released on January 16th at Arcview’s private Investor Forum in L.A. This first of its kind report finds that regulated marijuana sales in North America totaled $6.7 billion in 2016, a 30 percent increase from 2015. Sales are projected to grow at a compound annual growth rate of 25 percent, from $6.7 billion in 2016 to an estimated $20.2 billion by 2021."
Also the MJ has a great potential for CGRA. Read this article gives us more on MJ business.
"A new 2016 Arcview Market Research study shows North American Marijuana sales to top $20.2 Billion by 2021. The executive summary of this groundbreaking report was released on January 16th at Arcview’s private Investor Forum in L.A. This first of its kind report finds that regulated marijuana sales in North America totaled $6.7 billion in 2016, a 30 percent increase from 2015. Sales are projected to grow at a compound annual growth rate of 25 percent, from $6.7 billion in 2016 to an estimated $20.2 billion by 2021."
Somebody is trying to sake the tree it's not going to work
Today is the last day you could bay at this rate tomorrow it could turn around. Watch
This could happen tomorrow, unless the last minute buyers jump in before it hit over a dollar again soon.
Time to go to the next level.
Something is happening and the company is not in a possion to let us know anything now. You have to be patient and wait until they tell us. It could be a earth shatering news to put this to a higher level but you have to wait and be patient. Do not listern to the opposit side views and get frustrated. If you have money still not too late to buy some more and hold.
This is for CGRA's longs if you have not read this before please do so now only little patience needed to see this rising up. Hope see the upword movement soon.
"Bill Wright, CEO of CGrowth Capital, Inc. stated, "We have a robust, non-dilutive, thriving company. Revenues are now beginning to post into our fourth quarter financials and we fully expect these revenues to continuing growing. This has never been an adventure with overnight success -- it has taken time, patience, the right relationships, and a whole lot of work -- but we are there now and revenues will continue to build as we expand the facilities, properties, and leases under our control."
The Company continues to make progress on completing its domestic audits in preparation for uplisting to a higher exchange. In addition, management met with auditors in the United Kingdom to ensure smooth transition of data between all groups. Additional information will be provided on this subject as further developments are made."
Be Patient that's what needed now.
Besides the next financial reporting and FDA approval there are other things also happening which I am pretty sure would push the price of this stock much, much higher than the current price. March will be an interesting month for this stock. Don't forget it was trading at $11 at one point reaching that and beyond is very much possible in the near future.This is a stock to buy and hold to get the maximum benefit.
You call this a dump, last couple of days total shares traded below 400,000 and today below 200,000 I think there is no dilution of dumping by CEO as suggested by some. This will do well with the next update by the company.
Dont worry about others, you hang on to your GEM this is going to be moving up to $1.00 when the next update is put out. It could be any moment be little more patient.
Expecting to open tomorrow at 3.60 and to move up steadly to 3.75 or higher. When the next news comes out this will go Berserk, watch folks no joke.
Look at the barchart 100% Strong Buy recommended.
http://old.barchart.com/quotes/stocks/EVOK
2017 with in six months, watch baby CGRA going up to $1.00 sooner than later.
I hear there was some restriction on the oil production placed by the previous Government now Trump has removed the band and encouraging the small oil producers to increase the output so the energy prices could be brought down. This was one of his election promises. Oil prices are firming up and I am sure producers like CGRA are bound to gain a lot by this policy.
This is fake I don't believe at all. I am not selling a single share to anyone.
Previously somebody posted and I was only replying to his message. There us no lawsuit what so every, Somebody keeps on posting to steal our shares cheap. If you have read the previous messages you wouldn't asked me this question. CGRA is a very transparent company doing legal business therefore, there is no concern any thing wrong to happen here.
Major lawsuits against CGRA now in play...Not true lawsuit for what? They are doing legal business and very transparent in all that is done and said to the investors. Where did you get this info regarding the lawsuit???? Strange it's completely false and not true
We may close around .0159
That's a good sign as it's holding above $3.00 today. Hope to have more news from the company soon.
My advise is, hang on to your shares this may be worth over $20 dollars if the company try to sell this to a big Pharma company with multi natioanl connections. It could happen un-aware to the investors be smart and watch.
I like this part of the paragraph in the news.
"The number of shares of common stock to be outstanding after this offering is based on 12,350,360 shares outstanding as of September 30, 2016 and excludes:
1,275,624 shares of common stock issuable upon the exercise of options outstanding as of September 30, 2016, at a weighted average exercise price of $4.04 per share; 3,323,876 shares of common stock issuable upon the exercise of warrants outstanding as of September 30, 2016, at a weighted average exercise price of $3.29 per share; and
666,264 shares of common stock reserved for future issuance under our 2013 equity incentive award plan and our 2013 employee stock purchase plan as of September 30, 2016.
Except as otherwise indicated, all information in this prospectus supplement assumes no exercise by the underwriter of its option to purchase up to an additional shares of our common stock.
Dont worry this will trade in and around $10 to $15 range when FDA approves the drug for markting.
I don't think so. Delay in releasing the news does not mean company is failing in their promises. There will be surprises when the next release comes out. Cheer up.
share prices may go up and down but sometime you will be caught up unware when the next news is put out. Company is working on in differnt direction to make this a success story after the last FDA delay in accepting the drug. Now things are happening in correct direction, only we need to have the news to comfirm the FDA final say one this. Other matters are being worked out by the company as well. I hear lots of big players are interested to have jv with this company.